Australia’s Clinical Trial Advantage
Cost Efficiency & Funding Optimisation

 

Clinical trials can be expensive, but they don’t have to derail your budget. By partnering with Linear in Australia, you can take advantage of one of the most cost-effective clinical trial ecosystems in the world, without compromising on data quality or compliance.

Australia’s generous Refundable R&D Tax Incentive turns clinical trial spend into immediate cash flow with a 43.5% rebate on eligible trial costs.

At Linear, we help international biotech and pharma companies capitalise on this financial advantage while delivering high-quality, early-phase research with speed and precision.

Combine this with world-class infrastructure, FDA-recognised quality standards, and faster study startup, and you’ve got an unbeatable formula for biotech success.

Why Global Sponsors Choose Australia
And Linear

43.5% Rebabte with Strategic support to optimise tax rebate claims
No IND Required
93% Phase I trials were approved in 4 -6 Weeks
94.5% Cohorts Dosed on Time
World-class Phase I, Early Phase trial expertise

Tailored solutions for complex clinical trials,
engineered for speed, quality and precision.

More than a place to conduct trials – a partner in your entire clinical research journey. We facilitate every step of your clinical journey, from design to delivery and provide expert guidance on Australia’s innovative clinical trial frameworks, including the fast-track trial pathway and generous R&D incentives.